Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > NanoInk Appoints Russel A. Bantham to Its Board of Directors

Abstract:
NanoInk, Inc., an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries, announced today the appointment of Russel A. Bantham to its Board of Directors.

NanoInk Appoints Russel A. Bantham to Its Board of Directors

SKOKIE, IL | Posted on April 28th, 2008

„We‚re thrilled to have Russel Bantham join our esteemed Board of Directors,‰ said Jim Hussey, CEO, NanoInk. „With over 35 years of experience and leadership in the health care and pharmaceutical industries, Russel will be a valuable asset to our board.‰

Mr. Bantham worked at the Pharmaceutical Research and Manufacturers of America (PhRMA) from 1995 to 2005. As its executive vice president and COO, he was responsible for operations and had a staff of 160 with an annual budget in excess of $200 million. Before becoming COO at PhRMA, Mr. Bantham was senior vice president, general counsel and secretary where he was responsible for legal affairs and general management of PhRMA including strategy; science and regulatory affairs; and federal, state and international legislation and regulation.

Prior to PhRMA, Mr. Bantham spent 25 years at Bristol-Myers Squibb in a variety of positions, most recently as vice president and associate general counsel.

"Having spent the majority of my career in the health care and pharmaceutical industries, I understand the unique challenges NanoInk faces in bringing its brand protection solutions to the marketplace," said Bantham. "I look forward to advising the management team in its efforts to fuel the company‚s growth."

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPNŇ, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair, and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 100 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, the University of Illinois at Urbana-Champaign, and the Georgia Institute of Technology

For more information, please click here

Contacts:
David Gutierrez
Dresner Corporate Services
NanoInk
312-780-7204


Joshua Taustein
Dresner Corporate Services
NanoInk
312-780-7219

Copyright © NanoInk, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results July 27th, 2017

Strange electrons break the crystal symmetry of high-temperature superconductors: Brookhaven Lab scientists discover spontaneous voltage perpendicular to applied current that may help unravel the mystery of high-temperature superconductors July 27th, 2017

Getting closer to porous, light-responsive materials: A new flexible material changes its porous nature when exposed to light July 27th, 2017

First Capacitive Transducer with 13nm Gap July 27th, 2017

Law enforcement/Anti-Counterfeiting/Security/Loss prevention

Leti Announces Backside Shield that Protects Microchips from Physical Attacks March 8th, 2017

NUS engineers develop low-cost, flexible terahertz radiation source for fast, non-invasive screening: Novel invention presents promising applications in spectroscopy, safety surveillance, cancer diagnosis, imaging and communication February 1st, 2017

Strength of hair inspires new materials for body armor January 18th, 2017

Dressing a metal in various colors: DGIST research developed a technology to coat metal with several nanometers of semiconducting materials January 17th, 2017

Announcements

Rice U. scientists map ways forward for lithium-ion batteries for extreme environments: Paper details developments toward high-temperature batteries July 27th, 2017

Ultracold molecules hold promise for quantum computing: New approach yields long-lasting configurations that could provide long-sought “qubit” material July 27th, 2017

Atomic discovery opens door to greener, faster, smaller electronic circuitry: Scientists find way to correct communication pathways in silicon chips, making them perfect July 27th, 2017

Physicists gain new insights into nanosystems with spherical confinement: Enormous potential for the targeted delivery of pharmaceutical agents and the creation of tailored nanoparticles July 27th, 2017

Patents/IP/Tech Transfer/Licensing

Argonne National Laboratory’s Continuous ALD Technology Licensed Exclusively to Forge Nano July 7th, 2017

Aculon Expands NanoProof® Product Line for Electronics Waterproofing Technology: With growing market opportunities Aculon Launches NanoProof® 8 with Push Through Connectivity™ and NanoProof® DAB a syringe application May 30th, 2017

NREL’s Advanced Atomic Layer Deposition Enables Lithium-Ion Battery Technology: May 10th, 2017

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

Appointments/Promotions/New hires/Resignations/Deaths

Nanometrics Announces Retirement Plans of CEO Timothy Stultz: Dr. Stultz to Continue as Director May 25th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Francis Alexander Named Deputy Director of Brookhaven Lab's Computational Science Initiative February 16th, 2017

Nanobiotix appoints senior executive from pharmaceutical industry, as Chief Operating Officer: Oncology industry veteran to oversee operations and product commercialization February 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project